Lehrstuhl für Geburtshilfe und Frauenheilkunde

Association between event-free survival and overall survival in early-stage triple-negative breast cancer (2024) Huang M, Fasching P, Haiderali A, Xue W, Pan W, Karantza V, Yang F, et al. Journal article, Review article Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer (2024) Fasching P, Decker T, Hartkopf A, Nusch A, Heinrich BJ, Kurbacher C, Fuchs R, et al. Journal article ABC7 Consensus: Assessment by a German Group of Experts (2024) Ditsch N, Untch M, Fasching P, Busch S, Ettl J, Haidinger R, Jackisch C, et al. Journal article Bedeutung der parametrischen und molekularen Bildgebung für das therapeutische Management des Mammakarzinoms (2024) Hack C, Wetzl M, Schmidt D, Beckmann M Journal article Random forest algorithm identifies miRNA signatures for breast cancer detection and classification from patient urine samples (2024) Maurer J, Rübner M, Kuo CC, Klein B, Franzen J, Wittenborn J, Kupec T, et al. Journal article A Survival Analysis Approach to Predicting Severe Leukopenia in Advanced Breast Cancer Patients (2024) Vodenčarević A, Kreuzeder J, Wöckel A, Fasching P Conference contribution Impact of CCND1 amplification on the prognosis of hormone receptor–positive, HER2-negative breast cancer patients—correlation of clinical and pathological markers (2024) Hanf D, Fasching P, Gaß P, Beckmann M, Hack C, Heindl F, Häberle L, et al. Journal article Comparative assessment of breast volume using a smartphone device versus MRI (2024) Behrens A, Hübner H, Häberle L, Stamminger M, Zint D, Heindl F, Emons J, et al. Journal article Germline copy number variants and endometrial cancer risk (2024) Stylianou CE, Wiggins GA, Lau VL, Dennis J, Shelling AN, Wilson M, Sykes P, et al. Journal article A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center. (2024) Cuba L, Dürr P, Geßner K, Häcker B, Fietkau R, Siebler J, Pavel ME, et al. Journal article